Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmology News
Conversation with Gil Kliman, MD, about Silicon Valley Bank
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the Silicon Valley Bank collapse and its impact on investing and innovation in the field of ophthalmology with Gilbert H. Kliman, MD.
Wearing multiple hats: How to multitask and balance career paths outside of clinical practice
Dagny Zhu, MD, Cathleen M. McCabe, MD, and Laura M. Periman, MD, talk with Cynthia A. Matossian, MD, FACS, about the multitude of career pathways in ophthalmology and balancing career with family.
Log in or Sign up for Free to view tailored content for your specialty!
Overall risk for hydroxychloroquine retinopathy low, increases with higher doses
The overall risk for incident retinopathy in patients who received hydroxychloroquine for 5 or more years was low but progressively increased with higher doses, according to researchers.
Positive results announced from phase 2 trial of oral MS therapeutic
Clinical-stage biopharmaceutical company Clene Inc. announced proof-of-concept evidence of potential neuroprotective effects of CNM-Au8, an oral therapeutic for patients with stable relapsing-remitting MS.
Inebilizumab reduces B-cell subsets in neuromyelitis optica spectrum disorder attacks
Treatment with inebilizumab was associated with reduction in aquaporin-4 antibody titers and B cells for those with neuromyelitis optica spectrum disorder, according to an expert at ECTRIMS 2022.
App-based assessment tool may be useful for rapid sideline concussion diagnosis
CHICAGO – An app-based cognitive assessment tool set baseline scores for college football players and may be useful in rapid sideline concussion diagnosis, according to a poster at the 2022 American Neurological Association meeting.
New model may help assess chronic uveitis risk in juvenile idiopathic arthritis
A validated prognostic tool using common clinical markers could help clinicians evaluate patients with juvenile idiopathic arthritis for chronic uveitis risk, according to data published in Arthritis & Rheumatology.
Amydis launches phase 1/2a trial to evaluate novel retinal tracer in patients with ALS, PD
Amydis Inc. announced that patient enrollment in underway for a phase 1/2a trial to evaluate AMDXP-2011P, a retinal imaging agent that targets protein biomarkers in patients with Parkinson’s disease and ALS.
Dr. Mali’s AAO 2022 Annual Meeting Hot Topics Preview
In this episode, I share my preview of the hot topics for the upcoming AAO 2022 annual meeting, including my thoughts on ocular gene therapy and new treatments in the works.
Women in Business: An Interview with FIGS' Heather Hasson and Trina Spear
Dagny Zhu, MD, talks with Trina Spear and Heather Hasson, co-founders and co-CEOs of FIGS Scrubs, about they help female physicians feel confident and perform their best, their initiatives to celebrate healthcare workers and address gender disparities in the medical workforce and more.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read